The 2015 Antitrust Writing Awards
The winners have been announced and Competition Policy International is pleased that 8 of our articles have been nominated and Nicholas Levy‘s article Expanding EU Merger Control to Non-Controlling Minority Shareholdings: A Sledgehammer to Crack a Nut? won an award for Business Article. Our other nominees include:
Academic Article Nominees
The Beneficent Monopolist by Allen Grunes and Maurice Stucke
The Proposed Damages Directive: The Real Lessons from the United States by Robert Lande
Assessing Unfair Pricing Under China’s Anti-Monopoly Law for Innovation-Intensive Industries by David Evans, Vanessa Yanhua Zhang & Xinzhu Zhang
Business Article Nominees
The Competitive Significance Of Brands by Deven Desai and Spencer Weber Waller
Repeal the FTAIA! (Or At Least Consider It as Coextensive with Hartford Fire) by Robert Connolly
The Emperor’s Clothes Laid Bare: Commitments Creating the Appearance of Law, While Denying Access to Law by Philip Marsden
Chinese Antitrust Institutions—Many Cooks in the Kitchen by Adrian Emch
Deterrence and Efficiency Considerations Warrant an Expansive Reading of the FTAIA by David Barth
Featured News
Federal Judge Signals Revisions Likely in DOJ Case Targeting Live Nation Monopoly
Jan 22, 2025 by
CPI
American Airlines and JetBlue Agree to $2 Million Legal Fee Settlement with U.S. States
Jan 22, 2025 by
CPI
Federal Judge Dismisses Class Action Alleging Inflated Yacht Commission Fees
Jan 22, 2025 by
CPI
Doug Gurr Appointed Interim Chairman of UK’s Competition Authority
Jan 22, 2025 by
CPI
LinkedIn Faces Lawsuit Over Alleged Misuse of Customer Data for AI Training
Jan 22, 2025 by
Amanda Adams
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan